The Alzheimer’s Treatment Controversy
Implications of Accelerated Drug Approvals

July 20th, 2021 Part of: Policy Controversies.
The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals Live Online Q&A with Aaron Kesselheim, Professor of Medicine, Harvard Medical School, and Director, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women’s Hospital Presented jointly with Reuters Tuesday, July 20, 2021 Watch on YouTube The recent controversy surrounding the FDA approval of a new Read More…